Largest health care pharmaceutical companies by total assets
Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.
Pfizer leads the 61 health care pharmaceutical companies ranked by total assets, at PLN 836B, ahead of Johnson & Johnson (PLN 800.1B) and Sanofi (PLN 565B). Figures as of 19 Nov 2026, 14:21 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- PfizerPLN 836B
- Median
- PLN 14.2B
- Combined market value
- PLN 20.32T
- Countries
- 10
Market values as of .
All countries▾
Health Care▾
Pharmaceuticals▾
| # | Company | Total assets ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | PfizerPFE · Health Care | PLN 836B | PLN 642.3B | PLN 112.69 | 1.44% down | 15% up | ||
| 2 | Johnson & JohnsonJNJ · Health Care | PLN 800.1B | PLN 2.64T | PLN 1,095.20 | 2.15% down | 34% up | ||
| 3 | SanofiSNY · Health Care | PLN 565B | PLN 454.4B | PLN 189.24 | 0.86% down | 4% down | ||
| 4 | Merck & CoMRK · Health Care | PLN 549.7B | PLN 1.36T | PLN 553.35 | 3.90% down | 45% up | ||
| 5 | AbbVieABBV · Health Care | PLN 538B | PLN 2.03T | PLN 1,148.66 | 2.33% down | 25% up | ||
| 6 | AstraZenecaAZN · Health Care | PLN 458.1B | PLN 1.11T | PLN 717.93 | 1.93% down | 1% up | ||
| 7 | Eli LillyLLY · Health Care | PLN 451.7B | PLN 4.95T | PLN 5,553.33 | 2.32% down | 33% up | ||
| 8 | NovartisNVS · Health Care | PLN 445.6B | PLN 1.18T | PLN 623.35 | 2.46% down | 25% up | ||
| 9 | Takeda PharmaceuticalTAK · Health Care | PLN 390.2B | PLN 272.9B | PLN 85.42 | 1.71% down | 51% up | ||
| 10 | Bristol-Myers SquibbBMY · Health Care | PLN 361.6B | PLN 488.9B | PLN 239.20 | 2.92% down | 30% up | ||
| 11 | Abbott LaboratoriesABT · Health Care | PLN 348.3B | PLN 726.7B | PLN 419.61 | 0.22% down | 16% down | ||
| 12 | GSKGSK · Health Care | PLN 325.8B | PLN 391.1B | PLN 195.10 | 1.34% down | 5% up | ||
| 13 | Novo NordiskNVO · Health Care | PLN 323.6B | PLN 697.9B | PLN 158.36 | 3.12% down | 17% down | ||
| 14 | Teva Pharmaceutical IndustriesTEVA · Health Care | PLN 163.7B | PLN 197.9B | PLN 169.60 | 0.92% down | 74% up | ||
| 15 | Regeneron PharmaceuticalsREGN · Health Care | PLN 162.9B | PLN 392.8B | PLN 3,797.39 | 1.28% down | 28% up | ||
| 16 | ViatrisVTRS · Health Care | PLN 149.4B | PLN 93.4B | PLN 81.45 | 0.83% down | 99% up | ||
| 17 | Vertex PharmaceuticalsVRTX · Health Care | PLN 103B | PLN 546.2B | PLN 2,154.46 | 0.42% up | 27% up | ||
| 18 | GrifolsGRFS · Health Care | PLN 87.8B | PLN 23.2B | PLN 34.02 | 1.85% down | 0% up | ||
| 19 | Royalty PharmaRPRX · Health Care | PLN 78.8B | PLN 158.6B | PLN 275.79 | 0.01% down | 79% up | ||
| 20 | ZoetisZTS · Health Care | PLN 62.1B | PLN 139.6B | PLN 343.66 | 2.50% up | 26% down | ||
| 21 | Elanco Animal HealthELAN · Health Care | PLN 53.6B | PLN 53.6B | PLN 107.23 | 3.29% up | 26% up | ||
| 22 | GenmabGMAB · Health Care | PLN 51.7B | PLN 126.2B | PLN 204.70 | 1.91% down | 70% up | ||
| 23 | Jazz PharmaceuticalsJAZZ · Health Care | PLN 46.8B | PLN 63.9B | PLN 995.08 | 2.93% up | 41% up | ||
| 24 | BeOne MedicinesONC · Health Care | PLN 32.9B | PLN 185.2B | PLN 1,620.92 | 2.34% down | 16% up | ||
| 25 | United TherapeuticsUTHR · Health Care | PLN 31.6B | PLN 98.7B | PLN 2,318.68 | 1.16% down | 22% up | ||
| 26 | BioMarin PharmaceuticalBMRN · Health Care | PLN 30.5B | PLN 47.8B | PLN 246.71 | 4.99% up | 17% up | ||
| 27 | Dr. Reddy's LaboratoriesRDY · Health Care | PLN 24.8B | PLN 50.2B | PLN 60.16 | 1.28% up | 8% up | ||
| 28 | Roivant SciencesROIV · Health Care | PLN 22.9B | PLN 112.7B | PLN 155.55 | 0.05% up | 91% up | ||
| 29 | Alnylam PharmaceuticalsALNY · Health Care | PLN 19.9B | PLN 80.4B | PLN 600.01 | 4.54% down | 66% down | ||
| 30 | Amneal PharmaceuticalsAMRX · Health Care | PLN 14.8B | PLN 30.6B | PLN 87.87 | 3.60% up | 90% up | ||
| 31 | Ionis PharmaceuticalsIONS · Health Care | PLN 14.2B | PLN 18.3B | PLN 110.00 | 1.59% up | 63% down | ||
| 32 | PTC TherapeuticsPTCT · Health Care | PLN 11.6B | PLN 20.2B | PLN 241.89 | 0.22% down | 21% down | ||
| 33 | AlkermesALKS · Health Care | PLN 10B | PLN 31.6B | PLN 188.16 | 3.08% up | 66% up | ||
| 34 | InsmedINSM · Health Care | PLN 9.1B | PLN 105.6B | PLN 481.13 | 1.69% down | 40% down | ||
| 35 | Legend BiotechLEGN · Health Care | PLN 7B | PLN 12.7B | PLN 65.26 | 0.87% up | 41% down | ||
| 36 | Ligand PharmaceuticalsLGND · Health Care | PLN 6.3B | PLN 24B | PLN 1,199.66 | 1.67% up | 50% up | ||
| 37 | Ascendis PharmaASND · Health Care | PLN 5.8B | PLN 71.2B | PLN 1,085.69 | 0.32% down | 29% up | ||
| 38 | CytokineticsCYTK · Health Care | PLN 5.7B | PLN 28.7B | PLN 206.11 | 0.64% down | 19% down | ||
| 39 | Arrowhead PharmaceuticalsARWR · Health Care | PLN 5.6B | PLN 24.5B | PLN 173.14 | 0.28% up | 13% up | ||
| 40 | Madrigal PharmaceuticalsMDGL · Health Care | PLN 5.1B | PLN 37.1B | PLN 1,598.75 | 5.67% down | 27% down | ||
| 41 | TG TherapeuticsTGTX · Health Care | PLN 4.3B | PLN 40.1B | PLN 265.55 | 5.44% up | 117% up | ||
| 42 | Praxis Precision MedicinesPRAX · Health Care | PLN 3.8B | PLN 34.3B | PLN 1,225.69 | 0.04% up | 86% up | ||
| 43 | Cogent BiosciencesCOGT · Health Care | PLN 3.8B | PLN 19.4B | PLN 111.69 | 0.14% down | 20% down | ||
| 44 | BridgeBio PharmaBBIO · Health Care | PLN 3.8B | PLN 61B | PLN 313.30 | 1.58% up | 21% up | ||
| 45 | Mirum PharmaceuticalsMIRM · Health Care | PLN 3.4B | PLN 24.2B | PLN 371.45 | 0.59% up | 34% up | ||
| 46 | Corcept TherapeuticsCORT · Health Care | PLN 3.4B | PLN 29.8B | PLN 272.25 | 3.25% down | 10% down | ||
| 47 | Belite BioBLTE · Health Care | PLN 3.1B | PLN 25.5B | PLN 627.44 | 0.94% down | 43% up | ||
| 48 | Spyre TherapeuticsSYRE · Health Care | PLN 3.1B | PLN 38.7B | PLN 407.48 | 8.15% up | 332% up | ||
| 49 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | PLN 3.1B | PLN 30B | PLN 381.74 | 0.06% down | 129% up | ||
| 50 | Summit TherapeuticsSMMT · Health Care | PLN 3B | PLN 33.7B | PLN 42.17 | 1.59% down | 36% down | ||
| 51 | Axsome TherapeuticsAXSM · Health Care | PLN 2.8B | PLN 28.3B | PLN 538.16 | 1.43% down | 6% down | ||
| 52 | Protagonist TherapeuticsPTGX · Health Care | PLN 2.7B | PLN 33.3B | PLN 510.69 | 2.00% up | 51% up | ||
| 53 | ABIVAXABVX · Health Care | PLN 2.6B | PLN 29.5B | PLN 336.67 | 2.11% up | 32% down | ||
| 54 | Travere TherapeuticsTVTX · Health Care | PLN 2.4B | PLN 19.4B | PLN 201.77 | 1.68% down | 45% up | ||
| 55 | Edgewise TherapeuticsEWTX · Health Care | PLN 2.2B | PLN 18.2B | PLN 166.15 | 1.59% down | 86% up | ||
| 56 | Dianthus TherapeuticsDNTH · Health Care | PLN 2.1B | PLN 19B | PLN 337.28 | 3.45% down | 108% up | ||
| 57 | Oruka TherapeuticsORKA · Health Care | PLN 2B | PLN 26.1B | PLN 384.51 | 0.60% down | 255% up | ||
| 58 | Rhythm PharmaceuticalsRYTM · Health Care | PLN 1.9B | PLN 33.1B | PLN 478.08 | 2.08% up | 18% up | ||
| 59 | Definium TherapeuticsDFTX · Health Care | PLN 1.8B | PLN 16B | PLN 116.95 | 0.88% down | 168% up | ||
| 60 | ErascaERAS · Health Care | PLN 1.6B | PLN 19.4B | PLN 55.26 | 0.94% down | 395% up | ||
| 61 | VeradermicsMANE · Health Care | PLN 612.9M | PLN 21.2B | PLN 501.46 | 0.62% down | 231% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 4.0161 PLN).
Questions and answers
Which health care pharmaceutical companies rank first by total assets?
Pfizer (PLN 836B), Johnson & Johnson (PLN 800.1B) and Sanofi (PLN 565B) are the top three of the 61 health care pharmaceutical companies ranked by total assets as of 19 Nov 2026, 14:21 UTC.
How many health care pharmaceutical companies are in this ranking?
61 are ranked by total assets.
What are these health care pharmaceutical companies worth together?
The 61 health care pharmaceutical companies ranked by total assets have a combined market value of PLN 20.32T as of 19 Nov 2026, 14:21 UTC.
What does ranking by total assets measure?
Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest health care pharmaceutical companies by total assets”, data as of 19 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?sector=health-care&by=total-assets
Underlying data: Yahoo Finance; SEC EDGAR.